Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...

American companies are investing more in their future and getting a better return on their investments than overseas peers, ...

BMO Capital Markets analyst Brian Pitz noted in a report that Google Network "is a lower-margin business relative to Search and YouTube," and that the company pays out to partners most of the ad ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

Google illegally acted to preserve “monopoly power” in the ad-tech business, a federal judge ruled Thursday. It’s the second ...

Tariff-driven volatility has redefined what's considered a "normal" day of bond-market trading, with traders contemplating "a wider scope of conceivable outcomes" as the global trade war unfolds, said ...

Trump could use the findings of the probe to impose certain trade restrictions on pharma products, including tariffs.

Pfizer said on Monday it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...

The carnage in the stock market following President Donald Trump's April 2 unveiling of sweeping tariffs on virtually all U.S. trade partners has been extraordinary - but it's a historic surge in long ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

The economy and the markets are "under surveillance" as we cover the latest in finance, economics and investment.